HOME › DRUGS › DICLOFENAC POTASSIUM
ACTIVE SUBSTANCE / INN

DICLOFENAC POTASSIUM

Brand name(s): CATAFLAM, CAMBIA, ZIPSOR, DICLOFENAC POTASSIUM
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA020142
NDA022165
ACTIVE SUBSTANCE
Diclofenac Potassium
REGULATORS
FDA
SPONSORS / MAH
WATSON LABS TEVA, ASSERTIO SPECLTY, PH HEALTH
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DICLOFENAC POTASSIUMANDA202964PH HEALTHPrescription
DICLOFENAC POTASSIUMANDA075152WATSON LABS TEVADiscontinued
CATAFLAMNDA020142NOVARTISDiscontinued
CAMBIANDA022165ASSERTIO SPECLTYPrescription
ZIPSORNDA022202ASSERTIO SPECLTYPrescription
CATAFLAMANDA076561AMICI PHARMAPrescription

FULL INTELLIGENCE ON DICLOFENAC POTASSIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →